The Art of Dodging Bullets: How Covid-19 Drug Manufacturers and Providers Plan to Escape Tort Liability
SMU Science and Technology Law Review · 01.01.2021 · 24 (1) · 113
DOI: 10.25172/smustlr.24.1.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift SMU Science and Technology Law Review, online erschienen am 01.01.2021. Verfasst von Ruan Meintjes.
Abstract (Originalsprache)
Prior to his time at SMU, Ruan served as the Chief Operating Officer at a specialty healthcare company in North Texas where he oversaw the company's clinical, surgical, laboratory, and research divisions.Outside of school, Ruan enjoys spending time with his wife
Zitieren
APA
Meintjes, R. (2021). The Art of Dodging Bullets: How Covid-19 Drug Manufacturers and Providers Plan to Escape Tort Liability. SMU Science and Technology Law Review, 24(1), 113. https://doi.org/10.25172/smustlr.24.1.5
Vancouver
Meintjes R. The Art of Dodging Bullets: How Covid-19 Drug Manufacturers and Providers Plan to Escape Tort Liability. SMU Science and Technology Law Review. 2021;24(1):113. doi:10.25172/smustlr.24.1.5
BibTeX
@article{Meintjes2021,
author = {Meintjes, Ruan},
title = {The Art of Dodging Bullets: How Covid-19 Drug Manufacturers and Providers Plan to Escape Tort Liability},
journal = {SMU Science and Technology Law Review},
year = {2021},
volume = {24},
number = {1},
pages = {113},
doi = {10.25172/smustlr.24.1.5}
}
EUVIMED